Navigation Links
Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes
Date:1/7/2009

By the time pancreatic cancer is discovered, it is often late stage (as has been reported about actor Patrick Swayze) and survival rates are low. Dr. Aaron Chevinsky, a surgical oncologist specializing in pancreatic, liver and gastrointestinal (GI) cancers wasn't satisfied with that reality and has created a groundbreaking team approach to improve communication among specialists and improve outcomes for patients.

Morristown, NJ (PRWEB) January 7, 2009 -- Patrick Swayze's interview regarding pancreatic cancer will air on a Barbara Walters special on January 7. It is the first time he is discussing his Stage 4 diagnosis and battle with the disease.

By the time pancreatic cancer is discovered, it is often late stage and survival rates are low. Dr. Aaron Chevinsky, a surgical oncologist specializing in pancreatic, liver and gastrointestinal (GI) cancers in Morristown, New Jersey, wasn't satisfied with that reality and has created a groundbreaking team approach to improve communication among specialists and improve outcomes for patients. While this team approach isn't new, the execution is; multidisciplinary panels are often more focused on policy than diagnoses and treatment specifics.

Dr. Chevinsky is a surgical oncologist specializing in pancreatic, liver and gastrointestinal (GI) cancers at Allied Surgical Group in Morristown, N.J.; chief of surgical oncology at the Carol G. Simon Cancer Center at Morristown Memorial Hospital; and clinical professor of surgery at UMDNJ in Newark, N.J. In October 2008, Dr. Chevinsky was recognized for his groundbreaking work in the multidisciplinary approach to cancer treatment by the American College of Surgeons Cancer Liaison Physicians.

Dr. William L. Diehl and Dr. Mitchel S. Carter from Allied Surgical Group also serve on the multidisciplinary team with Dr. Chevinsky.

The American Cancer Society predicted that, in 2008, about 37,680 people in the United States would be found to have pancreatic cancer and about 34,290 would die of the disease (www.cancer.org).

EDITOR'S NOTE: Dr. Chevinsky is available to discuss all aspects of pancreatic cancer diagnosis and treatment, including the implentation of his team approach. A patient (65-year-old former nurse) who was uniquely and successfully treated for pancreatic cancer by Dr. Chevinsky's multidisciplinary team is also available for media interviews.

About Allied Surgical Group
Allied Surgical Group includes world-class surgeons who have provided state-of-the-art surgery to patients and New Jersey's finest doctors for more than three decades. Allied Surgical Group's eight board-certified surgeons include Mitchel S. Carter, M.D., FACS; Aaron Chevinsky, M.D., FACS; William L. Diehl, M.D., FACS; Carey Dolgin, M.D., FACS; Leah S. Gendler, M.D., FACS; Edward R. McLean Jr., M.D., FACS; Michael David Most, M.D.; and David S. Ward, M.D., FACS.

Areas of expertise include oncology; vascular, advanced laparoscopic and obesity surgery; and minimally invasive surgery. Together, the doctors care with compassion and integrity for patients throughout the tri-state region. Allied Surgical Group is located at 261 James St., Suite 2G, Morristown, N.J., and in the Carol G. Simon Cancer Center at Morristown Memorial Hospital. For more information, call 973-267-6400 or visit www.alliedsurgical.org.

###

Read the full story at http://www.prweb.com/releases/2009/01/prweb1836894.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nationally-Recognized Georgia Diabetes Project Honored
2. Cancer stem cell subpopulation drives metastasis of human pancreatic cancer
3. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
4. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
5. Protein Gives Clues to Pancreatic Cancer
6. The most important candidate genes for pancreatic stone formation
7. Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread
8. Elusive pancreatic progenitor cells found in mice
9. Pancreatic cancer: The smaller the tumor, the better your chances, study shows
10. Treatment Combo for Pancreatic Cancer Has Limited Benefit
11. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: